Asthma Clinical Trial
Official title:
Feasibility of Developing an Effective Asthma Intervention Using CBPR Methods
The purpose of this study is to identify community resources and challenges in improving the
health of community members with asthma.
The primary goal of this project is to use Community-Based Participatory Research
methodology to develop interventions aimed at improving asthma management in high-risk
African American asthmatics. This "ground-up" longterm approach has never been tested before
in asthmatics. The primary goal of this study will be accomplished with four specific aims:
Aim 1. Conduct focus groups to identify barriers to asthma management in the target
population.
Aim 2. Use a community advisory board (CAB) consisting of participants selected from the
various focus groups to gather information about solutions for the above barriers.
Aim 3. Use the information from the CAB to develop an intervention to improve asthma self
management behaviors in the target population.
Aim 4. Refine the developed intervention based on feedback from focus groups conducted in
Aim 1.
Volunteer will be asked to respond to several questions that address their perceptions about
asthma. Volunteers will also be asked to discuss their beliefs about asthma. Everyone in the
group will be given an opportunity to answer questions. Volunteers can decide that they no
longer want to participate in the group discussion at any time.
The discussion will last from 1.5 - 2 hours. The focus group discussion will have a maximum
of 10 people.
We will be audio and video taping the discussion so that we do not miss any information that
volunteers share with us. The audio and video tapes will not be shared with anyone outside
our staff.
Volunteer participation in this study is voluntary and there will be no negative
consequences if volunteers decide not to participate. Volunteers are also free to withdraw
from this study at any time. Withdrawal or refusal to participate will not affect health
care services or other rights.
;
Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|